Concern Over Ability to Sell Product: “The passage of the Inflation Reduction Act of 2022 may negatively impact our ability to sell our product candidates, if approved, profitably”
All entries for: Context Therapeutics
November 9, 2023
Context Therapeutics
Negative Outlook
Philadelphia, PA
1-50 employees
1-50 employees
Disease Area: Oncology
Drug Type: Biologic
August 9, 2023
Context Therapeutics
Negative Outlook
Philadelphia, PA
1-50 employees
1-50 employees
Disease Area: Oncology
Drug Type: Biologic
May 10, 2023
Context Therapeutics
Negative Outlook
Philadelphia, PA
1-50 employees
1-50 employees
Disease Area: Oncology
Drug Type: Biologic
November 9, 2022
Context Therapeutics
Negative Outlook
Philadelphia, PA
1-50 employees
1-50 employees
Disease Area: Oncology
Drug Type: Biologic
